Sign up to read this article for FREE!
After signing up, you'll start to receive regular news updates from us.
IDBS Acquires InforSense to Provide End-to-End Solutions for Research & Development Data Management
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
IDBS has announced that it has concluded an unconditional agreement to acquire InforSense Ltd (InforSense), a company providing award-winning scientific and business intelligence (BI) technologies, in an all-cash transaction. The acquisition will complete in July.
InforSense’s data integration technologies and web-based interactive analytics perfectly complement IDBS’ suite of secure, context-rich data management solutions. This transaction is expected to create a unique supplier who can deliver the entire capture, integration and decision-making infrastructure for R&D organizations worldwide.
With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine. The InforSense brand, its products and partnerships will continue to be developed, marketed and supported around the world.
This announcement comes shortly after IDBS announced the agreement with the University of Cambridge (UK) under which IDBS is to provide data management solutions to the Department of Chemistry, to improve data sharing across its broad network of academic groups in the UK and elsewhere, and marks the start of an ongoing informatics collaboration that will provide leading-edge technologies for commercialization.
InforSense’s data integration technologies and web-based interactive analytics perfectly complement IDBS’ suite of secure, context-rich data management solutions. This transaction is expected to create a unique supplier who can deliver the entire capture, integration and decision-making infrastructure for R&D organizations worldwide.
With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine. The InforSense brand, its products and partnerships will continue to be developed, marketed and supported around the world.
This announcement comes shortly after IDBS announced the agreement with the University of Cambridge (UK) under which IDBS is to provide data management solutions to the Department of Chemistry, to improve data sharing across its broad network of academic groups in the UK and elsewhere, and marks the start of an ongoing informatics collaboration that will provide leading-edge technologies for commercialization.
